This was also verified by correlating the PSMC2 expression levels and the clinical characteristics of tumors in HCC patients (P < 0.05, Table 2) and by Pearson correlation analysis (Supplementary Table S3). This evidence concerns the gene PSMC2 and hepatocellular carcinoma.